November 2009

November 30

Bayer Schering Pharma
Bayer Schering Pharma Starts Phase III Trial with Florbetaben
Development of PET tracer florbetaben for beta-amyloid imaging in patients with Alzheimer’s disease is progressing as planned » more

23 November

Bayer plc
Over £1,000 raised for Children in Need
Over 100 employees at Bayer House attended Ocean Clean’s fundraising event recently, raising an amazing £1,162.50 in aid of Children in Need. » more

November 19

Bayer Healthcare
Company statement
Bayer Healthcare today confirmed that it is to appeal the decision by NICE to deny NHS funding for Nexavar® (sorafenib), a treatment for a type of primary liver cancer known as advanced hepatocellular carcinoma (HCC). » more

November 17

Bayer MaterialScience
Bayer MaterialScience invests in high-tech products for
Bayer MaterialScience has entered into an agreement to acquire PolyBioMed Ltd. based in Sheffield, United Kingdom, thereby expanding its product portfolio for medical technology » more

November 11

Bayer Diabetes Care
New research in time for World Diabetes Day
shows that parents are confused about type-1 diabetes and there is a need for education » more

November 11

Bayer AG
Bayer strengthens sustainability commitment
Extensive program with global lighthouse projects launched - Focus on the fields of health care, nutrition and climate protection » more

November 2

Bayer Schering Pharma
Men Urged to "Revive Your Drive"

Men across the UK are being urged to ‘Revive Your Drive’ following the launch of a new campaign to raise awareness of Testosterone Deficiency Syndrome (TDS).

» more